Understanding the Costs and True Benefits of SDOH Investments

Join us on Tuesday, May 4, 2021 from 3:00 p.m. - 4:00 p.m. ET for a webinar that is part of a series which seeks to promote serious evidence-based discussions related to costs, value and allocation of health care spending. 

AcademyHealth, in collaboration with the National Pharmaceutical Council, hosted a webinar, Understanding the Costs and True Benefits of SDOH Investments, as part of a Health Spending webinar series, which seeks to promote serious evidence-based discussions related to costs, value, and allocation of health care spending and how those expenditures can best generate improved health outcomes. Access the summary blog here. Watch the archived webinar on demand.

Over the last few years, there have rightly been major investments across payers, foundation, and other entities in programs and data collection related to the Social Determinants of Health (SDOH). Still, effectively measuring the impact and ROI of these investments remains a major challenge. This webinar aims to generate a broader conversation on how to design and evaluate SDOH programs from a cost perspective, better understand which with other health care spending might be most impactful, and what additional data is needed to accomplish these goals.

Learning Objectives:

  • Review findings from a recent analysis of SDOH programs and potential economic benefit
  • Discuss how organizations may choose to be more targeted with SDOH efforts from a true cost/benefit perspective
  • Explore how we might define success for SDOH programs moving forward.
     

Moderator:

Garth N. Graham, MD, MPH
Director and Global Head of Healthcare and Public Health, Google/YouTube

Presenters:

Robert W. Dubois, MD, PhD
Interim President and CEO, National Pharmaceutical Council (NPC)

Evelyn Gallego, MBA, MPH, CPHIMS
CEO and Founder, EMI Advisors LLC

Andrew Renda, MD, MPH
Vice President, Bold Goal and Population Health Strategy, Humana


Watch on demand.